<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Psychiatry</journal-id><journal-id journal-id-type="publisher-id">IJPsy</journal-id><journal-title-group><journal-title>Indian Journal of Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0019-5545</issn><issn pub-type="epub">1998-3794</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21776131</article-id><article-id pub-id-type="pmc">2982081</article-id><article-id pub-id-type="publisher-id">IJPsy-34-273</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>AN IMMUNOMODULATOR IN THE TREATMENT OF SCHIZOPHRENIA : A DOUBLE-BLIND STUDY</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Agarwal</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Agarwal</surname><given-names>A.K.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Tewari</surname><given-names>S.C.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Dalal</surname><given-names>P.K.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Bahuguna</surname><given-names>L.M.</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Ex. Senior Resident, Department of Psychiatry, K.G&#x02032;s Medical College, Lucknow.</aff><aff id="aff2"><label>2</label>Professor and Head, Department of Psychiatry, K.G&#x02032;s Medical College, Lucknow.</aff><aff id="aff3"><label>3</label>Assistant Professor, Department of Psychiatry, K.G&#x02032;s Medical College, Lucknow.</aff><aff id="aff4"><label>4</label>Assistant Professor, Department of Psychiatry, K.G&#x02032;s Medical College, Lucknow.</aff><aff id="aff5"><label>5</label>Senior Research Officer, Department of Pathology, K.G.&#x02032;s Medical College. Lucknow.</aff><author-notes><corresp id="cor1"/></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>1992</year></pub-date><volume>34</volume><issue>3</issue><fpage>273</fpage><lpage>277</lpage><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Psychiatry</copyright-statement><copyright-year>1992</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>In a double blind study, the immunomodulator drug levamisole was administered along with chloropromazine to 18 schizophrenic patients, and efficiency of the combination was compared to that of chloropromazine along with placebo administered to 16 schizophrenic patients. The decrease in T suppressor cell count found in both groups at benchmark was found to be corrected in the patients receiving levamisole and this increase in T suppressor cell count was significantly correlated with the improvement in psychosis. The findings provide evidence in favour of the autoimmune hypothesis of schizophrenia.</p></abstract></article-meta></front></article>